Thomas Lee Ortel

Conference Int J Lab Hematol · August 2019 INTRODUCTION: Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening adverse reaction of heparin. Laboratory evaluation of HIT is often not available within a reasonable time. We evaluated the HemosIL® HIT-Ab(PF4-H) (Instrumentation Labor ... Full text Link to item Cite

Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.

Conference Thromb Res · March 2017 BACKGROUND: Ambulatory cancer patients at high-risk for venous thromboembolism (VTE) can be identified using a validated risk score (Khorana score). We evaluated the benefit of outpatient thromboprophylaxis with dalteparin in high-risk patients in a multic ... Full text Link to item Cite

Bridging anticoagulation in patients who require temporary interruption of warfarin therapy for an elective invasive procedure or surgery (the bridge trial)

Conference JOURNAL OF THROMBOSIS AND HAEMOSTASIS · June 1, 2015 Link to item Cite